Literature DB >> 12040466

Immunomodulation by apoptosis-inducing caspases for an influenza DNA vaccine delivered by gene gun.

S Sasaki1, K-Q Xin, K Okudela, K Okuda, N Ishii.   

Abstract

Apoptosis-inducing caspases have been tested for immunomodulatory effect on a gene gun-delivered DNA vaccine which expresses influenza hemagglutinin. Attenuated murine caspase 2 and a chimera of murine caspase 2 prodomain and human caspase 3 strongly enhanced humoral and cell-mediated immune response to hemagglutinin when they were co-administered with an immunogen DNA. In contrast, wild-type caspases did not enhance the DNA-raised immune response. Caspase dose-dependent antibody response curve revealed that the antibody level was in inverse relation to the amount of administered caspase. These findings indicate that bland apoptosis of antigen-harboring cells can elicit enhanced immune responses. Extensive apoptosis interferes with the generation of immune response. Gene gun delivery involving caspases elicited type-2 immune responses that characterized with dominant IL-4 and IgG1 production. ELISPOT assays showed that CD4 T cells were preferentially activated, while CD8 T cell response remained at marginal level. Using attenuated caspases for gene gun DNA vaccination is a useful approach to amplify type-2 immune responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12040466     DOI: 10.1038/sj.gt.3301696

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  6 in total

1.  DNA vaccines and apoptosis: to kill or not to kill?

Authors:  Wolfgang W Leitner; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

2.  Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.

Authors:  Jonathan Cenna; Gene S Tan; Amy B Papaneri; Bernhard Dietzschold; Matthias J Schnell; James P McGettigan
Journal:  Vaccine       Date:  2008-09-18       Impact factor: 3.641

3.  Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity.

Authors:  Fumihiko Takeshita; Toshiyuki Tanaka; Tomoko Matsuda; Miyuki Tozuka; Kouji Kobiyama; Sukumar Saha; Kiyohiko Matsui; Ken J Ishii; Cevayir Coban; Shizuo Akira; Norihisa Ishii; Koichi Suzuki; Dennis M Klinman; Kenji Okuda; Shin Sasaki
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Enhanced synergistic antitumor effect of a DNA vaccine with anticancer cytokine, MDA-7/IL-24, and immune checkpoint blockade.

Authors:  Seyed Mohammad Miri; Behzad Pourhossein; Seyed Younes Hosseini; Mohsen Keshavarz; Shohreh Shahmahmoodi; Mohammad Reza Zolfaghari; Seyed Reza Mohebbi; Ali Gorji; Amir Ghaemi
Journal:  Virol J       Date:  2022-06-25       Impact factor: 5.913

5.  Differences in methodology, but not differences in viral strain, account for variable experimental outcomes in laboratories utilizing the cottontail rabbit papillomavirus model.

Authors:  Nancy M Cladel; Jiafen Hu; Karla K Balogh; Neil D Christensen
Journal:  J Virol Methods       Date:  2009-12-29       Impact factor: 2.014

6.  Analysis of the effect of promoter type and skin pretreatment on antigen expression and antibody response after gene gun-based immunization.

Authors:  Rajesh Vij; Zhonghua Lin; Kellen Schneider; Dhaya Seshasayee; James T Koerber
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.